CALCIMEDICA, INC.
505 Coast Boulevard South, Suite 307
La Jolla, CA 92037
August 16, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Mr. Jimmy McNamara
| RE: | CalciMedica, Inc. |
Registration Statement on Form S-3
File No. 333-273949
Ladies and Gentlemen:
CalciMedica, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on August 18, 2023, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP and Rachel Lydon of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez at (858) 550-6157, or in his absence, Rachel Lydon of Cooley LLP at (858) 550-6107.
| Very truly yours, | ||
| CALCIMEDICA, INC. | ||
| By: | /s/ A. Rachel Leheny, Ph.D. | |
| Name: | A. Rachel Leheny, Ph.D. | |
| Title: | Chief Executive Officer | |
| cc: | John Dunn, CalciMedica, Inc. |
Carlos Ramirez, Cooley LLP
Rachel Lydon, Cooley LLP